Fundz
New|Fundz now works inside Claude2 min

Discover more near‑term opportunities with better event intelligence.

Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Richard J. Daly Appointed as Director of Aquestive Therapeutics

PUBLIC · AQSTSep 29, 2026

Position

Director

Company

Aquestive Therapeutics, Inc.

Richard J. Daly
WarrenBiotechnologyHealthcareHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Description

On September 29, 2026, Aquestive Therapeutics, Inc. announced the election of Richard J. Daly as a director of the Company

Company Information

Company

Aquestive Therapeutics, Inc.

Location

30 TECHNOLOGY DRIVE SOUTH

Warren, North Carolina, United States

About

Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company specializes in drug delivery technologies and is committed to improving patients' lives through its product pipeline. Their product candidate, Anaphylm™, aims to provide a new treatment option for severe allergic reactions. The company is headquartered in Warren, New Jersey.

Fundz sees it the moment Aquestive Therapeutics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Milosz
Senior decision-maker at this company
••••••••@••••••••

See Milosz's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Aquestive Therapeutics, Inc.'s next move

Learn about Strategic plan

Aquestive Therapeutics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.